Skip to main content
. 2023 Dec 21;32(1):47. doi: 10.1007/s00520-023-08221-4

Table 1.

Status literature search high-emetic-risk antineoplastic agents

Antiemetic drug group References included in the 2023 update Final number (duplicates deleted)
NK1 receptor antagonist 25 46
5-HT3 receptor antagonist 35
Dopamin2,3 receptor antagonists and multi-receptor targeting agents (e.g., olanzapine) 14
Corticosteroids 6
Cannabinoids 0
Total 80